Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The thyroid hormone receptor (TR) is a nuclear receptor that mediates the effects of thyroid hormones (T3 and T4) by regulating gene expression. It plays a crucial role in development, growth, and metabolism. TRs exist as different isoforms (TRα1, TRα2, TRβ1, and TRβ2) encoded by two genes (THRA and THRB). TRs bind to specific DNA sequences called thyroid hormone response elements (TREs) and, upon ligand binding, recruit coactivators to activate transcription. Dysregulation of TR function is implicated in various diseases.
Ligand-dependent and independent modulation of gene expression via binding to thyroid hormone response elements (TREs) on DNA, recruitment of coactivators or corepressors.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thyroid Hormone Receptor (TR).